Peritoneal Dialysis Market Set for 9.7% CAGR Growth Through 2032 - Persistence Market Research

The global peritoneal dialysis (PD) market is experiencing robust growth, driven by a combination of factors including the increasing prevalence of End-Stage Renal Disease (ESRD), growing aging populations, and a shift toward home-based care. Peritoneal dialysis is emerging as a preferred treatment modality for patients with kidney failure, particularly for those who have limited access to hemodialysis centers or who prefer a less intrusive, home-based therapy. The market is projected to grow from an estimated US$ 6.1 billion in 2025 to US$ 11.6 billion by 2032, at a compound annual growth rate (CAGR) of 9.7% during the forecast period (2025-2032).

Key growth drivers in the PD market include increasing ESRD prevalence, particularly due to diabetes and hypertension, a growing demand for home-based dialysis treatments, and the development of advanced technologies such as remote monitoring systems. A noteworthy trend is the rising demand for continuous ambulatory peritoneal dialysis (CAPD), particularly in rural and underserved regions where access to traditional dialysis centers is limited. As reimbursement policies increasingly favor home-based therapies, the PD market is expected to gain further traction. Leading companies in the kidney dialysis space are positioning themselves to capitalize on this growing opportunity, with an emphasis on localization and innovation.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35550

Key Highlights from the Report:

➤ The global peritoneal dialysis market size is expected to grow from US$ 6.1 billion in 2025 to US$ 11.6 billion by 2032.
➤ Continuous Ambulatory Peritoneal Dialysis (CAPD) remains the preferred dialysis type due to its simplicity and cost-effectiveness.
➤ Remote monitoring systems are transforming PD into a digitally enabled therapy, enhancing patient outcomes.
➤ The Asia Pacific region is projected to dominate the PD market due to its large ESRD patient population and insufficient hemodialysis infrastructure.
➤ PD fluids are forecasted to hold nearly 54.3% market share in 2025, driven by innovations in biocompatible and low-glucose solutions.
➤ The U.S. is expected to lead the North American PD market due to policy incentives and the rise of telehealth-enabled care models.

Market Segmentation

By Dialysis Type

The peritoneal dialysis market is primarily divided into two categories: Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). CAPD is projected to account for a significant share of the market, approximately 65.2% in 2025. This is largely due to its simplicity, cost-effectiveness, and suitability for low-resource settings. CAPD does not require electricity or machines, making it ideal for regions with unstable power supplies or limited healthcare infrastructure. In contrast, APD is gaining momentum in developed countries, particularly due to its ability to cater to modern lifestyle demands. This type of dialysis is typically performed overnight using a cycler machine, allowing patients to maintain daytime freedom for work or other activities.

By Product Type

In terms of product types, the peritoneal dialysis market is segmented into fluids, cyclers, and other accessories. PD fluids are expected to dominate the market, accounting for an estimated 54.3% of the market share in 2025. These fluids play a critical role in each PD session, making them a high-volume, recurring consumable. The development of new-generation biocompatible fluids with reduced glucose degradation products and neutral pH is expected to enhance clinical outcomes, further driving market growth. Cyclers, which are used for automated peritoneal dialysis, are also experiencing increased demand due to their ability to provide greater autonomy for patients, especially in urban healthcare settings. Companies such as Baxter International and Fresenius Kabi are actively developing new PD cyclers with integrated remote monitoring systems to improve treatment adherence and patient outcomes.

✅Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/peritoneal-dialysis-market.asp

Regional Insights

Asia Pacific

Asia Pacific is expected to account for a significant portion of the global peritoneal dialysis market, with an estimated share of 39.2% in 2025. The region is experiencing a growing burden of ESRD, particularly in countries like China and India, where the incidence of diabetes and hypertension is increasing. Additionally, the lack of sufficient hemodialysis centers in rural and underserved areas is driving the demand for alternative renal therapies like PD. Government-backed initiatives in countries such as China and India are supporting the growth of PD, with expanded reimbursement coverage and local manufacturing of PD fluids and equipment to reduce costs. However, adoption remains moderate in countries like Japan and Taiwan due to cultural preferences for in-center hemodialysis.

North America

In North America, the United States is expected to dominate the peritoneal dialysis market throughout the forecast period. This is largely due to policy reforms like the ESRD Treatment Choices (ETC) model, which incentivizes healthcare providers to increase the adoption of home dialysis therapies, including PD. With rising healthcare costs and a growing preference for home-based care, the U.S. market is experiencing an increased uptake of PD. The adoption of remote monitoring systems is also a key factor, as these platforms enable healthcare providers to adjust treatment settings in real-time, improving patient outcomes and reducing hospital visits. While Canada has a well-established PD program, recent data indicates a stagnation in growth due to the dominance of in-center dialysis services and an aging PD patient population.

Market Drivers

Several factors are propelling the growth of the peritoneal dialysis market:

Increasing Prevalence of ESRD: The global rise in chronic conditions such as diabetes and hypertension has significantly contributed to the increasing prevalence of ESRD. This has heightened the demand for renal replacement therapies, including peritoneal dialysis.

Growing Aging Population: As populations age worldwide, the incidence of ESRD is expected to rise, further pushing the demand for home-based dialysis therapies like PD. Elderly patients often prefer PD because it can be performed at home, reducing the need for frequent hospital visits.

Government Support and Reimbursement Policies: Various governments are increasingly supporting home-based dialysis through favorable reimbursement policies and funding initiatives. In countries like the U.S. and China, government-backed programs are helping to expand PD adoption, particularly in underserved regions.

Market Restraints

Despite the promising growth prospects, the peritoneal dialysis market faces several challenges:

Technological Reluctance among the Elderly: One of the primary barriers to the widespread adoption of PD, particularly Automated Peritoneal Dialysis (APD), is the reluctance of elderly patients to use cyclers and other complex devices. This is especially true in countries like Germany, Japan, and South Korea, where older patients may prefer in-center hemodialysis due to a lack of confidence in using machines.

Inadequate Training and Support: Many patients, particularly in rural regions, face difficulties in receiving the necessary training and support for home-based PD. The complexities involved in performing PD at home, including managing fluid exchanges and operating cyclers, can lead to patient frustration and poor treatment adherence.

Cultural Preferences for In-Center Dialysis: In some regions, cultural factors may hinder the acceptance of PD. For instance, in several European countries like Germany and France, in-center hemodialysis remains the preferred choice due to well-established healthcare infrastructure and reimbursement structures that prioritize in-center treatment over home therapies.

Market Opportunities

The peritoneal dialysis market also presents several opportunities for growth:

Shift from Reactive to Preventive Care: The increasing focus on early detection and management of chronic kidney disease (CKD) is creating an opportunity to integrate PD earlier in the disease progression. This shift could lead to higher adoption rates of PD, as patients begin home-based dialysis therapies earlier in their treatment journey.

Technological Advancements in Remote Monitoring: The integration of digital health tools and remote monitoring systems is improving the quality of care and driving patient adoption of PD. These innovations enable healthcare providers to track patient data in real-time, make adjustments to treatment plans, and ensure better treatment adherence.

Expansion in Emerging Markets: The growing demand for affordable healthcare solutions in emerging markets, particularly in Asia Pacific, offers significant opportunities for growth. Domestic manufacturers are already catering to local needs by developing cost-effective PD fluids and devices, which is driving market penetration in countries like India and China.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/35550

Reasons to Buy the Report

✔ Comprehensive analysis of the peritoneal dialysis market, covering key drivers, restraints, and opportunities.
✔ In-depth insights into the market segmentation by product type, dialysis type, and geographical region.
✔ Detailed coverage of the competitive landscape, including key players and emerging trends.
✔ Analysis of technological advancements such as remote monitoring systems and their impact on the market.
✔ Forecasts for market growth from 2025 to 2032, offering valuable insights for long-term strategic planning.

Company Insights
Key players in the peritoneal dialysis market include:

✦ Baxter International Inc.
✦ Fresenius Kabi AG
✦ Medtronic plc
✦ Utah Medical Products, Inc.
✦ Glomeria Therapeutics
✦ Poly Medicure Ltd.
✦ Cook Medical Inc.
✦ CardioMed Supplies, Inc.
✦ Medical Components, Inc.

Recent Developments

In June 2025, Vantive announced a US$ 1 billion investment to expand research and development in digitally-enabled therapies for peritoneal dialysis.

In October 2024, Baxter International revealed plans to restore pre-Hurricane Helene levels of new patient intakes and increase PD allocations to specific children's hospitals.

The peritoneal dialysis market is poised for significant growth, driven by advancements in technology, favorable government policies, and increasing demand for home-based treatments. As more patients and healthcare providers turn to PD, the opportunities for innovation and expansion in this space continue to grow.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.